Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges

Graft-versus-host disease (GVHD) is the leading cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Immunomodulation using regulatory T cells (Tregs) offers an exciting option to prevent and/or treat GVHD as these cells naturally function to maintai...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefazi, Mehrdad, Bolivar-Wagers, Sara, Blazar, Bruce R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469916/
https://www.ncbi.nlm.nih.gov/pubmed/34575843
http://dx.doi.org/10.3390/ijms22189676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469916/
https://www.ncbi.nlm.nih.gov/pubmed/34575843
http://dx.doi.org/10.3390/ijms22189676

Ejemplares similares